T1	Participants 55 84	experimental human influenza:
T2	Participants 235 242	humans;
T3	Participants 519 575	treatment of influenza in experimentally infected humans
T4	Participants 718 747	US university medical schools
T5	Participants 773 918	117 healthy adult volunteers (aged 18-40 years; median age, 21 years) who were susceptible (hemagglutination-inhibition antibody titer < or =1:8)
T6	Participants 2957 2985	experimental human influenza
